Novolin R

Phase 2Small molecule

SSun Yat-sen University

Novolin R is one of 16 small molecule programs targeting Smoking Behavior. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Smoking BehaviorActive, not recruiting

Smoking BehaviorPhase 2

Active, not recruiting

Competition

Competitive Landscape

15 competitors in Smoking Behavior

#DrugCompanyPhaseTrials

Chantix

PPrism Pharmaceuticals

Approved

1 2

Wellbutrin

Pitocin

1 4

Intuniv

PPromius Pharma, LLC

Phase 2

1 5

Nicorette

Pfizer

Phase 1

1 6

Bupropion SR

AAxsome Therapeutics, Inc.

Phase 2

1 7

Chantix

Prometrium

1 9

AXS-05

AAxsome Therapeutics, Inc.

Phase 2

1 10

CERC-501

Johnson & Johnson

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Critical Care1 trial

The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit

Completed·GGenesys·N/A·NCT00282594·317 enrolled

Smoking Behavior1 trial

Neuro Biomarkers of Smoking Behavior

Terminated·UUniversity of Illinois at Chicago·Phase 2·NCT03811951·4 enrolled

Type 2 Diabetic Patients1 trial

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

Completed·SSun Yat-sen University·N/A·NCT00147836·436 enrolled

Oral1 trial

A Study Evaluating the Bioavailability of Oral Insulin (N11005)

Completed·—·Phase 1·NCT04975022·12 enrolled

LAM1 trial

Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.

Completed·WWockhardt·Phase 1·NCT00596063·25 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Novolin R. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Novolin R compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Novolin R. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sun Yat-sen University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: SSun Yat-sen University

Novolin R

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Critical Care1 trial

Smoking Behavior1 trial

Type 2 Diabetic Patients1 trial

Oral1 trial

LAM1 trial

References

Drug Info

Quick Facts

Related News